Category Archives: Breast cancer
Physical Activity and Risk of Breast Cancer Among Postmenopausal Women
Physical activity has many health benefits, including weight loss and maintenance, improved insulin sensitivity and improved lipid profile. An analysis, which was based on the Nurses’Health Study, reported that moderate physical activity was associated with a reduced risk of postmenopausal … Continue reading
Aspirin Can Prevent From Several Common Cancers
If you are taking aspirin to prevent heart attack, you should be glad to know that you might also be protected from a variety of cancers. According to a new study published in Lancet, taking aspirin over a long period … Continue reading
Pertuzumab Plus Herceptin Shows Promise in Early Breast Cancer
Just after four cycles of neoadjuvant use, the combination of Roche’s pertuzumab, Herceptin (trastuzumab) and chemotherapy improved the rate of complete tumor disappearance by more than half compared to conventional therapy in patients with HER2-positive breast cancer. The results came … Continue reading
Breast and Endometrial Cancer – Causes, Symptoms, Diagnosis, Prognosis and Hormonal Treatment
Breast Cancer Breast cancer is the most commonly diagnosed cancer in women and the second leading cause of cancer death in the United States. It is estimated that the lifetime risk of developing breast cancer is one in eight, with … Continue reading
Soy Intake Lowers Recurrence of Hormone-Sensitive Breast Cancers
The intake of soy isoflavones among women with breast cancer has become a public health concern since these compounds have been found to have weak estrogenic effects. A study published in the Canadian Medical Association Journal, however, suggested soy intake … Continue reading
Cetuximab (Erbitux) Reduces Disease Progression in Triple Negative Breast Cancer
Patients with triple negative breast cancer usually have poor prognosis, but a new drug might soon be available to improve the survival in these patients. Mid-stage study results presented at the European Society for Medical Oncology congress indicated that cetuximab(Erbitux) … Continue reading